Chinese University of Hong Kong-Prince of Wales Hospital

Shatin OX1 3UJ

1 studies enrolling now · 5 studies all time

What they study most

Adult Nasal Type Extranodal NK/T-Cell Lymphoma, Extra-Adrenal Paraganglioma, Metastatic Adrenal Gland Pheochromocytoma, Metastatic Nasopharyngeal Carcinoma, Nonalcoholic Steatohepatitis (NASH), Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Paraganglioma, Recurrent Adrenal Gland Pheochromocytoma, Recurrent Nasopharyngeal Carcinoma, Recurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma, Recurrent Nasopharyngeal Undifferentiated Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7

Studies at this site

• Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer — Recruiting now
• Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer — Paused
• Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or Nasal Natural Killer T-Cell Lymphoma — Running, not enrolling
• HTD1801 in Adults With Nonalcoholic Steatohepatitis and Liver Fibrosis Who Have Type 2 Diabetes or Pre-Diabetes — Completed
• Pazopanib Hydrochloride in Treating Patients With Advanced or Progressive Malignant Pheochromocytoma or Paraganglioma — Stopped early